title: Methodology, biology and clinical applications of human mesenchymal stem cells.
abstract: Stem cells are known by their capacity of self-renewal and differentiation into at least one specialized cell type. Mesenchymal stem cells (MSCs) were isolated initially from bone marrow but are now known to exist in any vascularized organ or tissue in adults. MSCs have a great therapeutic potential, due to their ability to migrate to sites of tissue injury and secrete trophic factors that hasten endogenous repair. They have also been shown to present immunosuppressive properties that may be used in the treatment of autoimmune or graft-versus-host diseases. Clinical trials employing MSCs show that the therapy is safe, but the efficiency needs to be in tested in phase III and IV studies. We describe here protocols for the isolation of human MSCs from human bone marrow and adipose tissue. The safe use of these cells demand a thorough in vitro characterization, as described in protocols of immunophenotyping by flow cytometry and analysis of their capacity to differentiate into adipogenic, osteogenic, and chondrogenic lineages.
authors.affiliation: Programa de Pós-Graduação em Diagnóstico Genético e Molecular, Universidade Luterana do Brasil, Canoas, RS, Brazil.
authors.forename: Melissa
authors.initials: M
authors.lastname: Camassola
authors.forename: Luisa Maria Gomes
authors.initials: LM
authors.lastname: de Macedo Braga
authors.forename: Pedro Cesar
authors.initials: PC
authors.lastname: Chagastelles
authors.forename: Nance Beyer
authors.initials: NB
authors.lastname: Nardi
mesh_terms: D000273:Adipose Tissue / Q000166:cytology / Q000276:immunology; D001854:Bone Marrow Cells / Q000166:cytology / Q000276:immunology; D002469:Cell Separation; D002986:Clinical Trials as Topic; D005434:Flow Cytometry; D006801:Humans; D016130:Immunophenotyping; D045164:Mesenchymal Stem Cell Transplantation; D059630:Mesenchymal Stem Cells / Q000166:cytology* / Q000276:immunology